Trial intelligence / Profile preview

Pidotimod plus antibiotics vs antibiotics alone in community-acquired pneumonia

2013-001663-23Phase 4Active

Sponsor
IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
Start
Jun 2013
Modality
Small Molecules, Peptides
Countries
1
01

Overview

A Phase 4 trial of pidotimod in community-acquired pneumonia (CAP), bacterial pneumonia, sponsored by IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico. Started Jun 2013; status: active.

02

Drugs

pidotimod
03

Conditions

community-acquired pneumonia (CAP)bacterial pneumonia

Beyond the preview

Go deeper on 2013-001663-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001663-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call